In cardiac patients and preclinical cardiomyopathy and heart failure models, Atrogin1 and MuRF1 promote the progression of cardiomyopathy and premature death due to cardiac dysfunction and remodeling [48,50]. The gene discussed is FBXO32; the disease is heart failure.